Buy-Side Deal Origination
Targeted, proprietary sourcing for lower-middle-market PE funds, healthcare holding companies, and platform MSOs seeking strategic add-ons ($1M–$5M EBITDA target range).
Echelon
Healthcare Partners
MSO Growth Advisory & Buy-Side Deal Origination
We partner with leading clinical practice owners and lower-middle-market private equity funds to unlock equity, streamline back-office operations, and scale MSO platforms—delivering sustainable financial outcomes grounded in ethical practice.
The Dual Value Proposition
For Independent Practice Owners
Equity Realization
Monetize 60%–80% of your practice value today while retaining equity upside in the growing MSO platform.
Administrative Relief
Eliminate back-office friction—billing, HR, compliance, and payer contracting—so you can focus on patient care.
Preserve Legacy
Maintain your practice culture and local identity with zero clinical interference.
For Private Equity Partners
High-Conviction Origination
Access unbrokered, off-market clinical practices doing $1M to $5M+ in EBITDA.
Pre-Vetted Platforms
Deal candidates pre-screened for payer mix, provider retention, clean billing standards, and growth potential.
MSO Turnkey Structuring
Seamless navigation of CPOM (Corporate Practice of Medicine) regulations and Friendly PC alignment.
Core Services
Targeted, proprietary sourcing for lower-middle-market PE funds, healthcare holding companies, and platform MSOs seeking strategic add-ons ($1M–$5M EBITDA target range).
Strategic consulting for independent multi-location clinics looking to build, optimize, or recapitalize their Management Services Organization (MSO) back-office framework.
Guiding practice founders through majority and minority equity partnerships, succession planning, and growth capital deployment.
Investment Criteria
EBITDA Range
$1M – $5M
Target earnings profile for add-on and platform candidates
Revenue Range
$5M – $25M
Aligned with lower-middle-market clinical enterprises
Ethical Foundation & Operational Approach
We believe the highest financial valuations are a natural byproduct of exceptional patient care and ethical operations. Our advisory process prioritizes long-term platform stability, provider retention, and clinical integrity above short-term transactional velocity.
Confidential Inquiry
Whether you are a practice founder evaluating growth options or a PE partner seeking proprietary deal flow, let's schedule a discrete conversation.
Private, bilateral introductions only
Off-market dialogue with accredited institutional partners
Responses typically within one business day